Dr. Whiteside is an MD and PhD graduate ofthe University of Toronto and FRCP(C) in Internal Medicine and Nephrology. From1985 to 2005 she was a staff nephrologist at the University Health Network,Toronto, and clinician-scientist in the Department of Medicine. From 2000 to2005 she was Associate Dean Graduate and Inter-Faculty Affairs in the Facultyof Medicine and from 2006 to 2014 Dean of Medicine and Vice Provost Relationswith Health Care Institutions at the University of Toronto. In 2012 she wasrecognized with WXN Canada's Most Powerful Women Top 100 Award.Dr. Whiteside was awarded in 2007 ...

Dr. James Wright is a global leader in surgeryand has made important contributions to the care of Children. He was the first orthopedic surgeon to gain advanced clinical research training in north America and is a leader in applying evidence in orthopedics, which is transforming thecare of patients Worldwide. Nationally, his efforts have led to shortened surgical wait times for children. As Surgeon-in- Chief and Medical VP at Sickkids, one of the world's premier children's hospitals, his leadership has led to a culture of safety and innovation. He has received the highest research awards of ...

Professor, McGill University

Professor of Medicine and Experimental Medicine, Director of the Division of Allergy and Clinical Immunology, McGill University Christos Tsoukas is a Professor of Medicine and Experimental Medicine and Director of the Division of Allergy and Clinical Immunology at McGill University. A pioneer in HIV research, he played an important role in blood product safety in the 1980s. His academic interests include the treatment and management of HIV, therapeutic vaccines, and chronic inflammation as it relates to aging. He has served on advisory boards for the World Federation of Hemophilia, Health ...

Prof. Medicine, James McGill Chair & Medical Scientist, McGill University

Robyn Tamblyn has been an international leader in education. Following her PhD at McGill University, she continued her work at McGill on performance assessment but crucially began to analyze data about patient safety and public protection. Over two decades, she clarified the validity of medical licensing examinations; used health insurance data to clarify the reasons behind poor prescribing practices; and pioneered two integrated health data systems, IRIS-Quebec and Medical Office of the 21? Century (MOXXI), to improve prescribing practices and the quality and safety of health care for ...

Professor & Head, Neurology, University of British Columbia

Dr. A. Jon Stoessl, Professor of Neurology and Director of the Pacific Parkinson’s Research Centre is a world leader in research and clinical activities pertaining to Positron Emission Tomography and movement disorders, including Parkinson’s Disease. He is a pioneer in these fields and provided the first evidence of the placebo effect in Parkinson’s disease is mediated by the release of substantial levels of dopamine in the brain. He is also involved in international collaborations that have led to the discovery of new gene mutations that result in Parkinson-like disorders.

Professor, McGill University

Dr. Michael Shevell has devoted his career to improving the care of children with neurodevelopmenta disabilities, especially global developmental delay, intellectual disability and cerebral palsy. He has also focused on identifying subgroups at risk amongst critically ill newborns. His efforts have directly modified our clinical work with these populations targeting medical, diagnostic programmatic follow-up. Dr. Shevell is currently Chair of the Department of Pediatrics at McGill and Pediatrician-in-Chief of the McGill University Health Centre. His administrative efforts are shepherding a ...

Dr. David Spence, a clinician-scientist trained in Neurology, Internal Medicine and Clinical Pharmacology, has devoted his entire career to prevention of stroke. His clinical work has prevented an estimated 5,000 strokes, but his research, teaching and publications, by changing the way physicians approach stroke prevention, have prevented many more. He led many clinical trials of stroke prevention, including 4 major trials funded by NIH. He pioneered the understanding of pseudohypertension, co-discovered the effect of grapefruit on drug metabolism, pioneered the measurement of carotid ...

Professor, School of Population and Public Health, University of British Columbia

Martin T. Schechter is Professor and formerly, the Founding Director of the School of Population and Public Health in the Faculty of Medicine at the University of British Columbia. Dr. Schechter completed his BA in Mathematics at York University, his MA in Mathematics at UBC, his PhD in Mathematics at the Polytechnic Institute of NYU, his MD in Medicine at McMaster University and his MSc in Epidemiology at the University of Toronto. Dr. Schechter was a National Health Research Scholar and Scientist from 1986 to 1999 and then a CIHR Senior Investigator from 2000 to 2001. From 2001 to 2023, he ...

Ernesto Schiffrin has made seminal contributions to our understanding of the mechanisms leading and contributing to hypertension. He has delineated the role that hormones such as angiotensin, aldosterone and endothelin play in the regulation of the vasculature in hypertension. He characterized arteries involved in blood pressure elevation in patients with hypertension, and effects of treatment on their blood vessels, contributing to improving outcome for hypertensive patients. He is past President of the Canadian Hypertension Society and Chair of the High Blood Pressure Research Council of ...